Literature DB >> 20657543

Therapy: Low-dose flutamide for hirsutism: into the limelight, at last.

Francis de Zegher, Lourdes Ibáñez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657543     DOI: 10.1038/nrendo.2010.119

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Flutamide for androgen excess: low dose is best.

Authors:  Francis de Zegher; Lourdes Ibáñez
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-04       Impact factor: 1.814

2.  Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period.

Authors:  Roberto Paradisi; Stefano Venturoli
Journal:  Eur J Endocrinol       Date:  2010-04-06       Impact factor: 6.664

3.  Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day).

Authors:  I I Müderris; F Bayram; M Güven
Journal:  Gynecol Endocrinol       Date:  2000-02       Impact factor: 2.260

Review 4.  Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.

Authors:  Lourdes Ibáñez; Francis de Zegher
Journal:  Hum Reprod Update       Date:  2006-01-11       Impact factor: 15.610

5.  Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.

Authors:  Lourdes Ibáñez; Francis De Zegher
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

6.  Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

Authors:  Lourdes Ibáñez; Carme Valls; Sergi Cabré; Francis De Zegher
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

7.  Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.

Authors:  J Calaf; E López; A Millet; J Alcañiz; A Fortuny; O Vidal; J Callejo; F Escobar-Jiménez; E Torres; J J Espinós
Journal:  J Clin Endocrinol Metab       Date:  2007-06-12       Impact factor: 5.958

8.  Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

Authors:  Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Goya Enríquez; Luis del Río; Francis de Zegher
Journal:  Clin Endocrinol (Oxf)       Date:  2008-11-05       Impact factor: 3.478

9.  Flutamide hepatotoxicity.

Authors:  D K Wysowski; J L Fourcroy
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

Review 10.  Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

Authors:  Kathryn A Martin; R Jeffrey Chang; David A Ehrmann; Lourdes Ibanez; Rogerio A Lobo; Robert L Rosenfield; Jerry Shapiro; Victor M Montori; Brian A Swiglo
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

  10 in total
  4 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

Review 2.  Contemporary approaches to the management of polycystic ovary syndrome.

Authors:  Renato Pasquali
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-07       Impact factor: 3.565

3.  Hyperinsulinaemic androgen excess in adolescent girls.

Authors:  Lourdes Ibáñez; Ken K Ong; Abel López-Bermejo; David B Dunger; Francis de Zegher
Journal:  Nat Rev Endocrinol       Date:  2014-04-29       Impact factor: 43.330

Review 4.  Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment.

Authors:  Fahimeh Ramezani Tehrani; Mina Amiri
Journal:  Int J Endocrinol Metab       Date:  2019-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.